Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study

Affiliations

• ¹ Dermatology Practice Dr. Bernhard Korge, Oberstraße 75-77, 52349, Düren, Germany. [email protected].
• ² Clinique Sainte-Elisabeth, Place Louise Godin 15, 5000, Namur, Belgium.
• ³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.
• ⁴ The Lynde Institute for Dermatology and Lynderm Research Inc., 25 Main Street Markham N, Markham, ON, Canada.
• ⁵ Probity Medical Research, Markham, ON, Canada.
• ⁶ Department of Dermatovenerology, University Hospital Motol, Prague, Czech Republic.
• ⁷ University Hospital of Rennes (CHU de Rennes)-Pontchaillou, Rennes, France.
• ⁸ 2nd Department of Dermatology, Aristotle University School of Medicine-Papageorgiou General Hospital, Thessaloniki, Greece.
• ⁹ Antonio Cardarelli National Hospital, Naples, Italy.
• ¹⁰ University Hospital Igualada, Barcelona, Spain.
• ¹¹ UCB Pharma, Madrid, Spain.
• ¹² UCB Pharma, Brussels, Belgium.
• ¹³ UCB Pharma, Morrisville, NC, USA.
• ¹⁴ UCB Biosciences, Monheim am Rhein, Germany.
• ¹⁵ Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Salford, Greater Manchester, UK.
• ¹⁶ NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.